All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Rehan Khan

Rehan Khan

Rehan Khan
Institute of Nano Science and Technology (INST),
(An Autonomous Institute of Department of Science and Technology) Habitat Centre



Dr. Rehan Khan is working as a Scientist at Institute of Nano Science and Technology, Mohali, India. Currently his area of research is application of Cancer Biology, synthetic lethality & Cancer, nanochemoprevention of cancer. His main research interest is to develop novel drug targets for cancer treatment by exploiting chromosomal instability (CIN) genes. These CIN genes are cancer cell specific signatures and can be used for the selective killing of cancer cells. During his postdoctoral training, by using yeast/drosophila datasets, he was working on to develop synthetic lethal interactors of homologous recombination repair (HRR)-deficient cancer cells for synergistic killing of cancer cells only sparing normal cells.


Research Interest

Synthetic Lethality & Cancer, NanoChemoprevention, Development of Nanoformulation of Drugs, Photodynamic therapy (PDT) and Photothermal therapy (PTT) using nanoparticles, Combinatorial Therapy of PDT/PTT with Nanodrug for cancer treatment.